Board of Directors
Christopher J. Ainley
Managing director, Mid-Cap Equity Fund, Trust Company of the West. Investment fund manager at Putnam Securities and Morgan Guaranty Bank.

Seth N. Birnbaum
Founder and vice president of engineering for NeoGenesis Pharmaceuticals. Project engineer at DTI and Scripps Institute.

Thomas B. Hallowell
Investment counselor and trustee, Essex Street Associates. Former senior investment counselor, BankBoston. Director, ThermoCeramix Corporation. Co-founder, Stoneridge Childrens Montessori School, Beverly, MA.
 
Daniel A. Keshian
Managing Director, Fairhaven Capital. Former CEO of iPhrase Technologies, venture partner at Greylock, senior executive positions at Cisco, WebLine, Avid Technology, Gateway Design Automation Corporation.

Allen H. Michels
Founder and CEO of Mechtronics Nuclear, MacInstitute, Convergent, Ardent, Chronologic Simulations, Virtual Machine Works and NeoGenesis Pharmaceuticals.

Adam Stettner
Managing Director, Special Situations Fund

Hugh L. Warren
Professional Trustee, Loring, Wolcott & Coolidge

 

"The economics of the access-control model of information security do not scale; rather economics favor an accountability model focused on the monitoring of information use rather than the gatekeeping of information access."

DAN GEER, VP & CHIEF SCIENTIST, VERDASYS
 
About Us | Products | Solutions | Alliances | News & Events | Training | Contact Us | Customer Support
© 2008 Verdasys. All rights reserved. Terms of Use and Privacy Policy